Document Detail

The use of botulinum type A toxin in the treatment of idiopathic clubfoot: 5-year follow-up.
MedLine Citation:
PMID:  19700985     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Continued monitoring and reporting of outcomes in clubfoot patients are important for providing an indicator of functional outcomes and surveillance and treatment for problems or recurrences. The purpose of this study is to report the 5-year outcomes of the updated cohort of 44 patients with 65 idiopathic clubfeet treated with manipulation, casting, and Botulinum toxin A (BTX-A). METHODS: As part of the original study, the patients underwent the corrective treatment phase of manipulation and casting followed with BTX-A injection and then the maintenance phase of bracing. The patients were seen at regular intervals and a detailed clinical history was maintained for each patient including ankle range of motion, recurrences, and interventions for recurrences. RESULTS: Mean values for range of motion at the 5-year visit were 22.3 and 17.1 degrees for dorsiflexion with the knee in flexion and extension, respectively. Overall, 48% (31 of 65 clubfeet) successfully responded to a single BTX-A injection and experienced no recurrence over the follow-up period. At least 1 repeat BTX-A injection was required in 34 clubfeet, for an overall recurrence rate of 52%. Surgery was required in 10 clubfeet, and the overall surgical rate was 15.4%. CONCLUSIONS: Idiopathic clubfeet treated with BTX-A continued to show good outcomes at 2 to 5-year follow-up. The experience with this cohort provides support for the effectiveness of BTX-A in the initial correction and continued management of idiopathic clubfoot. LEVEL OF EVIDENCE: Levels III to IV. This is a prospective, nonexperimental clinical study investigating efficacy of an innovative treatment.
Christine M Alvarez; Mary A De Vera; Harpreet Chhina; Linda Williams; Kim Durlacher; Serap Kaga
Related Documents :
11392405 - Critical age of botulinum toxin treatment in essential infantile esotropia.
7735515 - Specific hyposensitization in patients allergic to parietaria officinalis pollen allergen.
20939855 - Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis ...
17321875 - Safety of percutaneous injection of bovine dermal crosslinked collagen for glottic insu...
21420125 - Effect of simple malrotation on percutaneous nephrolithotomy: a matched pair multicente...
17305675 - A new catheter technique for thoracic subarachnoid neurolysis in advanced lung cancer p...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pediatric orthopedics     Volume:  29     ISSN:  1539-2570     ISO Abbreviation:  J Pediatr Orthop     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-24     Completed Date:  2009-11-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8109053     Medline TA:  J Pediatr Orthop     Country:  United States    
Other Details:
Languages:  eng     Pagination:  570-5     Citation Subset:  IM    
Department of Orthopaedics, Faculty of Medicine, University of British Columbia, Vancouver BC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ankle Joint / physiopathology
Botulinum Toxin Type A / therapeutic use*
Child, Preschool
Clubfoot / physiopathology,  therapy*
Cohort Studies
Combined Modality Therapy
Follow-Up Studies
Knee Joint / physiopathology
Neuromuscular Agents / therapeutic use*
Prospective Studies
Range of Motion, Articular
Time Factors
Treatment Outcome
Reg. No./Substance:
0/Botulinum Toxin Type A; 0/Neuromuscular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effectiveness of botulinum A toxin as an adjunct to the treatment of clubfeet by the Ponseti met...
Next Document:  Distal focal femoral deficiency.